Yonsei Med J.  2009 Apr;50(2):293-295.

Topical Glycopirrolate for the Management of Hyperhidrosis in Herpetic Neuralgia

• Ladjevic N
• Likic-Ladjevic IS

Abstract

Herpes zoster is a relapse of varicella. In certain cases, long-term pain and hyperhidrosis have been noted. Appearance of herpes zoster during pregnancy is infrequent. We described hyperhidrosis and pain treatment using glycopirrolate cream in a pregnant woman with herpetic neuralgia. A 32 year old woman, 21 weeks pregnant with second child, complained to her gynecologist of the appearance of a vesicular rash on the left half of the forehead that progressed toward her left eyelid, accompanied by lancinating pain, allodynia, hyperhidrosis and small edema, blepharitis and conjunctivitis. Following clinical and laboratory tests, she was diagnosed with herpes zoster ophtalmicus. Aciclovir therapy was administered 800 mg orally five times daily for seven days. Pain therapy was initiated with amitriptilline. We discontinued amitriptilline therapy after 10 days because of appearance of unwanted side effects. After skin changes ceased, we introduced Lidocaine patch into pain therapy which reduced the allodynia, but not the lancinating pain and hyperhidrosis. At that time we began using glycopirrolate cream which reduced pain intensity by 28.5% within 24 hours, and completely eliminated hyperhidrosis. After 48 hours of use, the pain completely disappeared. During the Glycopirrolate cream therapy, there were no side effects. This is a first report to document that a topical Glycopirrolate cream has a beneficial effect in a patient with hyperhidrosis and herpetic neuralgia.

Keyword

Amitriptyline; glycopirrolate; herpes zoster; hyperhidrosis

MeSH Terms

Adjuvants, Anesthesia/administration & dosage/*therapeutic use
Administration, Topical
Adult
Female
Glycopyrrolate/administration & dosage/*therapeutic use
Herpes Zoster/*drug therapy/pathology
Humans
Neuralgia/pathology/*physiopathology
Pregnancy

Reference

1. Mounsey AL, Matthew LG, Slawson DC. Herpes zoster and postherpetic neuralgia: prevention and management. Am Fam Physician. 2005. 72:1075–1080.

2. Espana A, Redondo P. [Update in the treatment of herpes zoster.]. Actas Dermosifiliogr. 2006. 97:103–114.

3. Johnson RW, Whitton TL. Management of herpes zoster (shingles) and postherpetic neuralgia. Expert Opin Pharmacother. 2004. 5:551–559.

4. Gross G, Schöfer H, Wassilew S, Friese K, Timm A, Guthoff R, et al. Herpes zoster guideline of the German Dermatology Society (DDG). J Clin Virol. 2003. 26:277–289. discussion 291-3.

5. Hempenstall K, Nurmikko TJ, Johnson RW, A'Hern RP, Rice AS. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med. 2005. 2:e164.

6. Kim WO, Kil HK, Yoon DM, Cho Mj. Treatment of compensatory gustatory hyperhidrosis with topical glycopyrrolate. Yonsei Med J. 2003. 44:579–582.

7. Goldstein DS, Pechnik S, Moak J, Eldadah B. Painful sweating. Neurology. 2004. 63:1471–1475.

8. Ulus IH, Ozyurt G, Korfali E. Decreased serum choline concentrations in humans after surgery, childbirth, and traumatic head injury. Neurochem Res. 1998. 23:727–732.

9. Drummond PD. The mechanism of facial sweating and cutaneous vascular responses to painful stimulation of the eye. Brain. 1992. 115:1417–1428.